AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies released
In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting
KANABO Group Plc. (LON: KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical
Materia (the “Company”), a leading producer and distributor of medical cannabis in Europe, announces that its wholly-owned subsidiary Materia Malta Operating Ltd.
KANABO Group Plc. (LON: KNB), announces an extension to its existing contract between the GP Service and one of the
KANABO has released its first full-year financial results since becoming the second cannabis company in history to launch on the
European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up
FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history.
The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears
The deal, announced today(MON), is worth £14m. Patients can, for a set price of £39.99, get an appointment with a UK registered GP within half an hour and then get a prescription sent to one of 4,200 pharmacies within an hour for £7.49.
Kanabo Group Plc (LSE:KNB) the pan-European medical cannabis company that focuses on developing and commercialising cannabis-derived products for medical patients
Kanabo Group Plc (LSE:KNB), a medical cannabis and R&D Company that focuses on the distribution of cannabis-derived products for medical
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates
Kanabo, one of Europe’s fastest-growing medical cannabis R&D companies that focuses on the distribution of cannabis-derived products for medical patients,
KANABO’s proposed share-based purchase of high-profile medical cannabis business Materia Ventures is the ‘perfect match’, says Avihu Tamir, its founder
PROPOSALS to set a minimum valuation level for companies looking to list on the London Stock Exchange could limit the
THE London Stock Exchange will accept the first cannabis company in its 320-year history next month – marking a significant
THE UK can ride the global green wave to boost the domestic economy in the post-Covid, post-Brexit world, says a
We won’t spam you
